Alpha-Glycerophosphocholine (Alpha-GPC or α-GPC) is a cholinergic compound renowned for its cognitive-enhancing properties and its role in athletic performance optimization. This article provides an in-depth analysis of Alpha GPC's features, advantages, technical specifications, applications, and the background of its manufacturer, Hebei Finutra Biotech Co., Ltd..
Figure 1: Alpha GPC L-Alpha-Glycerylphosphorylcholine powder
Product Overview
Alpha GPC is a phospholipid and choline compound that serves as a precursor to acetylcholine, a neurotransmitter critical for memory, focus, and muscle control. Its ability to cross the blood-brain barrier makes it a valuable supplement for cognitive support and physical performance. The compound is also used in pharmaceutical intermediates and nutraceutical formulations.
Figure 2: Alpha GPC production process at Hebei Finutra Biotech Co., Ltd.
Key Features and Advantages
Alpha GPC offers a range of benefits, including:
- Cognitive Enhancement: Supports memory, focus, and mental clarity by increasing acetylcholine levels.
- Athletic Performance: Enhances strength, power output, and ketone body production in athletes.
- Cellular Health: Supports cell membrane integrity and may aid in preventing cognitive decline.
- High Purity: 99% purity with rigorous quality control measures.
Technical Specifications
| Parameter | Specification | Testing Method |
|---|---|---|
| Product Name | Alpha GPC | N/A |
| Molecular Formula | C8H20NO6P | N/A |
| CAS No. | 28319-77-9 | N/A |
| Assay (Alpha GPC) | 50% | Potentiometric titration |
| Appearance | Fine White Powder | Visual |
| Moisture Content | ≤3% | K.F |
| Heavy Metals | <10ppm | Colorimetry |
| Total Plate Count | <1000cfu/g | USP |
| Moulds and Yeast | <100cfu/g | USP |
| Coliforms | Negative | USP |
| Salmonella | Negative | USP |
| Packing | 25kg/drum | N/A |
| Storage | Cool, dry place; avoid direct sunlight | N/A |
| Shelf Life | Two Years | N/A |
Applications
Alpha GPC is widely used in the following areas:
- Nutraceuticals: As a cognitive enhancer in supplements for memory and focus.
- Pharmaceuticals: In the development of drugs targeting neurodegenerative disorders.
- Sports Nutrition: To improve athletic performance and recovery.
- Research: As a research tool for studying cholinergic systems.
Company Background
Hebei Finutra Biotech Co., Ltd. is a leading manufacturer of high-purity biochemical compounds, including Alpha GPC. Based in China, the company specializes in producing pharmaceutical intermediates and nutraceutical ingredients. Their commitment to quality is reflected in their adherence to international standards, such as non-GMO, BSE/TSE-free, and allergen-free certifications.
Quality Assurance
Hebei Finutra Biotech Co., Ltd. ensures the quality of Alpha GPC through rigorous testing protocols. The product meets the following criteria:
- Non-GMO and BSE/TSE-Free: Ensures safety and compliance with global regulations.
- Allergen-Free: Minimizes the risk of allergic reactions.
- Microbiological Safety: Free from harmful pathogens like Salmonella and coliforms.
Scientific Validation
According to research published by the National Institute of Standards and Technology (NIST), cholinergic compounds like Alpha GPC play a critical role in neurological function and metabolic processes. NIST's studies emphasize the importance of precise analytical methods for verifying the purity and efficacy of such compounds, aligning with Hebei Finutra Biotech Co., Ltd.'s quality control measures.
Conclusion
Alpha GPC is a versatile compound with significant applications in cognitive enhancement, athletic performance, and pharmaceutical research. Hebei Finutra Biotech Co., Ltd. stands out as a reliable supplier of high-quality Alpha GPC, backed by rigorous testing and adherence to international standards. For more information, visit their official website.
References
NIST Reference: National Institute of Standards and Technology (NIST). (2023). "Analytical Methods for Cholinergic Compounds." Retrieved from https://www.nist.gov.
Post time:Sep - 23 - 2025







